Home › Neuroendocrine Tumors › California

Pag-aaral pangklinika para sa Neuroendocrine Tumors sa California

13 pag-aaral para sa Neuroendocrine Tumors ang naghahanap ng mga kalahok sa mga site sa California.

Mga Lungsod sa California

Opisyal na teksto ng pag-aaral (English)

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Cedars-Sinai Medical Center, Beverly Hills
Norris Comprehensive Cancer Center, Los Angeles
Stanford Cancer Center, Palo Alto
at 2 pa

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06943755

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

UCSF Benioff Children's Hospital, San Francisco

Nagre-recruitPhase 1

24 Months – 18 Years · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06441331

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Hoag Memorial Hospital Presbyterian, Newport Beach

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07087054

Project: Every Child for Younger Patients With Cancer

Kaiser Permanente Downey Medical Center, Downey
City of Hope Comprehensive Cancer Center, Duarte
Loma Linda University Medical Center, Loma Linda
at 15 pa

Nagre-recruitObservasyonal na pag-aaral

Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

Crinetics Study Site, Duarte
Crinetics Study Site, Newport Beach
Crinetics Study Site, Orange
at 1 pa

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT07129252

CapTemY90 for Grade 2/3 NET Liver Metastases

UC San Diego, La Jolla

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT04339036

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

St Joseph Heritage Healthcare, Santa Rosa

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT03093116

Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Stanford University, Palo Alto

Nagre-recruitPhase 1/2

Edad 20 hanggang 99 · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT02174549

Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors

University of California, San Francisco, San Francisco

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT05746208

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

City of Hope, Duarte
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Stanford Cancer Institute, Stanford

Nagre-recruitPhase 1

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT04119024

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Cedars-Sinai Medical Center, Los Angeles

Nagre-recruit

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT04907643

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

University of Southern California, Los Angeles

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT06943521

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duarte
Massive Bio SYNERGY-AI site, Irvine
Massive Bio SYNERGY-AI site, La Jolla
at 3 pa

Nagre-recruitObservasyonal na pag-aaral

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.